Large study tracks brain tumor treatments to guide future care
NCT ID NCT07448480
First seen Mar 07, 2026 · Last updated Apr 29, 2026 · Updated 10 times
Summary
This study looks back at the outcomes of chemotherapy and targeted therapy in 1000 adults with recurrent malignant gliomas, including glioblastoma and anaplastic astrocytoma. Researchers will analyze survival and progression times to understand which treatments work best. The goal is to gather knowledge to improve treatment decisions for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blokhin's Russian Cancer Research Center
Moscow, 115478, Russia
Conditions
Explore the condition pages connected to this study.